©2010 Baishideng.
World J Gastroenterol. Aug 21, 2010; 16(31): 3865-3870
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3865
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3865
Table 1 Topics of meta-analyses of Helicobacter pylori eradication between 1992-2010
| Topics of meta-analysis | No. of studies |
| First-line triple therapies | 25 |
| PPI-based therapies | 22 |
| Ranitidine bismuth citrate-based therapies | 3 |
| Bismuth-based quadruple therapies | 2 |
| Non-bismuth-based quadruple therapies | 1 |
| Histamine H2 receptor blockers + two different antibiotics | 5 |
| Rescue (second- and third-line) therapies | 3 |
| Sequential therapies | 4 |
| Alternative therapies | 4 |
| Eradication in functional dyspepsia | 20 |
| Eradication in peptic ulcer | 10 |
| Effect of CagA status on eradication | 1 |
| Gastric cancer prevention | 5 |
| Eradication in children | 2 |
| Eradication in prevention of NSAID-ulcers | 1 |
| Eradication in extradigestive diseases | 5 |
| Effect of probiotics on eradication results | 5 |
| Eradication and antimicrobial resistance | 4 |
| Effect of CYP polymorphism on eradication | 2 |
| Adverse effects of eradication | 4 |
| Multiple topics | 11 |
| Total | 113 |
-
Citation: Buzás GM. First-line eradication of
Helicobacter pylori : Are the standard triple therapies obsolete? A different perspective. World J Gastroenterol 2010; 16(31): 3865-3870 - URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3865.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i31.3865